BiotechTube
Home/Corbus Pharmaceuticals/Sean Moran, CPA, MBA
SM

Sean Moran, CPA, MBA

Chief Financial Officer

Corbus Pharmaceuticals

Therapeutic Areas

OncologyMetabolic Disease

Corbus Pharmaceuticals Pipeline

DrugIndicationPhase
CRB-701Nectin-4 expressing solid tumors (e.g., Cervical Cancer, HNSCC, mUC)Phase 1
CRB-913Obesity and related conditionsPhase 1

Leadership Team at Corbus Pharmaceuticals

YC
Yuval Cohen, Ph.D.
Chief Executive Officer and Director
DD
Dr. Dominic Smethurst, MA MRCP
Chief Medical Officer
IH
Ian Hodgson, BSc (Hons), Ph. D.
Chief Operating Officer
View full Corbus Pharmaceuticals profile